The well known side effects of anticholinergic therapy led this class of drugs to fall into disfavor. Since then, inhaled anticholinergics have been developed that result in few side effects but many positive clinical outcomes. Ipratropium bromide has emerged as an important pharmacologic agent for use in chronic lung disease and asthma. This article reviews the science related to the use of ipratropium in adults and children and suggests implications for use in critical cars
Skip Nav Destination
Respiratory Pharmacology| May 01 1995
Anticholinergic Therapy in the Critically Ill Patient With Bronchospasm
Michele J. Geiger-Bronsky, RN, MSN
From the Professional Support Services Department, Long Beach Memorial Medical Center, Long Beach, California.
Reprint requests to Michele Geiger-Bronsky, RN, MSN, Clinical Nurse Specialist-Respiratory, Long Beach Memorial Medical Center, 2801 Atlantic Avenue, Long Beach, CA 90801-1428.
Search for other works by this author on:
AACN Adv Crit Care (1995) 6 (2): 287–296.
- Views Icon Views
- Share Icon Share
Michele J. Geiger-Bronsky; Anticholinergic Therapy in the Critically Ill Patient With Bronchospasm. AACN Adv Crit Care 1 May 1995; 6 (2): 287–296. doi:
Download citation file: